MedPath

THERACLION

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

High Intensity Focused Ultrasound Device in Patients With Autonomous Hyperfunctioning Thyroid Nodules

Early Phase 1
Terminated
Conditions
Autonomous Hyperfunctioning Thyroid Nodules
Interventions
Device: HIFU
First Posted Date
2014-06-23
Last Posted Date
2014-06-23
Lead Sponsor
Theraclion
Target Recruit Count
2
Registration Number
NCT02169687
Locations
🇫🇷

Hôpital Pitié Salpetrière, Paris, France

Feasibility Study Assessing the Treatment of Fibroadenomata With a Circumferential Sonication Treatment With HIFU

Not Applicable
Completed
Conditions
Breast Fibroadenoma
Interventions
Device: HIFU treatment
First Posted Date
2014-05-15
Last Posted Date
2018-05-30
Lead Sponsor
Theraclion
Target Recruit Count
50
Registration Number
NCT02139683
Locations
🇬🇧

Kings College London, Guy's & St Thomas' Hospitals, Department of Research Oncology, London, United Kingdom

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

Not Applicable
Completed
Conditions
Breast Fibroadenoma
Interventions
Device: Echopulse
First Posted Date
2013-12-13
Last Posted Date
2018-05-30
Lead Sponsor
Theraclion
Target Recruit Count
27
Registration Number
NCT02011919
Locations
🇩🇪

Tubingen University Hospital, Tubingen, Germany

Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU)

Phase 1
Completed
Conditions
Bone Metastasis
Interventions
Device: HIFU
First Posted Date
2013-01-10
Last Posted Date
2014-04-16
Lead Sponsor
Theraclion
Target Recruit Count
3
Registration Number
NCT01765907
Locations
🇫🇷

Institut Gustave Roussy, Villejuif, France

High Intensity Focused Ultrasound (HIFU) to Treat Breast Fibroadenoma

Not Applicable
Completed
Conditions
Breast Fibroadenoma
Interventions
Device: Ultrasonic ablation device
First Posted Date
2011-08-24
Last Posted Date
2014-04-09
Lead Sponsor
Theraclion
Target Recruit Count
24
Registration Number
NCT01422629
Locations
🇫🇷

Hôpital Américain de Paris, Neuilly Sur Seine, France

🇫🇷

Hôpital Jeanne de Flandre, CHU de Lille 2 Avenue Oscar Lambret, Lille, France

Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism

Not Applicable
Withdrawn
Conditions
Secondary Hyperparathyroidism
End Stage Renal Disease
Parathyroid Hyperplasia
Interventions
Device: Ultrasonic ablation device
First Posted Date
2011-08-22
Last Posted Date
2014-05-06
Lead Sponsor
Theraclion
Registration Number
NCT01421407
Locations
🇮🇹

Ospedale generale regionale "Miulli", Acquaviva delle Fonti, Italy

🇪🇸

Hospital Universitario Marquès de Valdecilla, Santander, Cantabria, Spain

🇮🇹

Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milano, Italy

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

Not Applicable
Active, not recruiting
Conditions
Breast Fibroadenoma
Interventions
Device: Ultrasonic ablation device
First Posted Date
2011-04-08
Last Posted Date
2024-04-11
Lead Sponsor
Theraclion
Target Recruit Count
20
Registration Number
NCT01331954
Locations
🇧🇬

University Hospital of Endocrinology (USBALE) "Acad. Ivan Penchev", Sofia, Bulgaria

Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment Procedure

Not Applicable
Completed
Conditions
Primary Parathyroid Adenomas
Interventions
Device: Ultrasonic ablation device
First Posted Date
2010-02-02
Last Posted Date
2014-05-06
Lead Sponsor
Theraclion
Target Recruit Count
5
Registration Number
NCT01060982
Locations
🇫🇷

Hôpital Privé des Peupliers, Paris, France

🇫🇷

Cochin Hospital, Paris, France

© Copyright 2025. All Rights Reserved by MedPath